Clinical Trial Update: Phase II Trial of Alisertib With Induction Chemotherapy in High-risk AML [Phase 2]

View source ↗

Summary

Phase II trial investigating alisertib in combination with induction chemotherapy for high-risk acute myeloid leukemia has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Alisertib (alisertib)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Acute Myeloid Leukemia | Phase 2 | Status: COMPLETED | Results posted: 2018-10-11